A GMP protocol for the manufacture of Tregs for clinical application
Infusion of regulatory T cells is a promising therapeutic strategy in organ transplantation to modulate the immune system, prevent rejection, minimize the need for pharmaceutical immunosuppression, and improve long-term transplant outcomes. Here we describe a GMP-compliant method we have used for th...
| Main Authors: | , , , , , |
|---|---|
| Format: | Book section |
| Language: | English |
| Published: |
Humana Press
2022
|